Wealth Advisors Of Iowa, LLC Abb Vie Inc. Transaction History

Wealth Advisors Of Iowa, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	BUY	$131.98 - $163.75 $119,573 - $148,357	906 Added 24.87%	4,549 $737,000
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $84,117 - $106,433	783 Added 27.38%	3,643 $493,000
Q3 2021 Nov 09, 2021	BUY	$106.4 - $120.78 $304,304 - $345,430	2,860 New	2,860 $309,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Wealth Advisors Of Iowa, LLC, based on Form 13F filings with the SEC.

Stay updated on Wealth Advisors Of Iowa, LLC with notifications on news.